To further validate these results, we collected clinical samples from 50 hepatocellular carcinoma patients and performed consecutive sectioning and immunohistochemical staining for NPC1 and the neutrophil marker CD11b (Fig. 5B). Here, ITGAM is linked to hepatocellular carcinoma.